Should You Buy Intuitive Surgical With the Stock Down 35%? Here's What History Says

Intuitive Surgical (ISRG) shares have declined 35% from their recent peak, prompting investors to question whether this is a buying opportunity. Historical patterns suggest that the stock has endured similar drawdowns in the past, only to rebound strongly.

Historical Drawdowns and Recoveries

Over its history, Intuitive Surgical has seen several declines exceeding 30%:

• 2008-2009: Dropped 60% during the financial crisis, then recovered 300% over three years.
• 2015: Fell 35% on regulatory concerns, then rallied 150% in the next two years.
• 2020: Declined 40% amid the pandemic, then surged 200% in 18 months.

Why Is the Stock Falling Now?

The current decline is attributed to:

• Slower growth in robotic surgery procedures post-pandemic.
• Increased competition from Medtronic and Johnson & Johnson.
• High valuations that left the stock vulnerable to a correction.

What This Means for Investors

While history does not guarantee future results, Intuitive Surgical has demonstrated resilience after major pullbacks. The company still dominates the surgical robotics market with over 80% market share and more than 8,000 da Vinci systems installed. Investors with a long-term horizon and tolerance for volatility may see an opportunity, but competitive and valuation risks remain.